What are the key differences between AbbVie (ABBV) and Johnson & Johnson (JNJ)?

Compare AbbVie (ABBV) and Johnson & Johnson (JNJ) side by side on Lunoo to see detailed feature differences, AI scores, and expert analysis.

How are AbbVie (ABBV) and Johnson & Johnson (JNJ) scored?

AbbVie (ABBV) has an AI score of 8.4/10 and Johnson & Johnson (JNJ) has an AI score of 9.5/10. Scores are based on features, user satisfaction, and overall quality analysis.

AbbVie (ABBV) vs Johnson & Johnson (JNJ) 2026 — Compared

AbbVie (ABBV)

Johnson & Johnson (JNJ)

WINNER Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ) edges ahead with a score of 9.5/10 compared to 8.4/10 for AbbVie (ABBV). While both are highly r...

AbbVie (ABBV)

8.4 Very Good

Dividend Stocks Get AbbVie (ABBV) open_in_new

emoji_events WINNER

Johnson & Johnson (JNJ)

9.5 Brilliant

Dividend Stocks Get Johnson & Johnson (JNJ) open_in_new

psychology AI Verdict

Johnson & Johnson (JNJ) edges ahead with a score of 9.5/10 compared to 8.4/10 for AbbVie (ABBV). While both are highly rated in their respective fields, Johnson & Johnson (JNJ) demonstrates a slight advantage in our AI ranking criteria. A detailed AI-powered analysis is being prepared for this comparison.

emoji_events Winner: Johnson & Johnson (JNJ)

verified Confidence: Low

Ready to decide? Get Johnson & Johnson (JNJ) arrow_forward

description Overview

AbbVie (ABBV)

AbbVie is a research-based biopharmaceutical company with a strong portfolio of drugs, including Humira. While facing patent expirations for some key products, AbbVie is actively investing in research and development to create new innovative therapies. The company offers a high dividend yield, currently around 4.0%, and has a history of dividend increases. Its suitable for investors seeking a high...

Johnson & Johnson (JNJ)

Johnson & Johnson is a diversified healthcare company operating in pharmaceuticals, medical devices, and consumer health. Its diverse business segments provide resilience against economic fluctuations and sector-specific challenges. Like P&G, J&J is a Dividend Aristocrat with a long history of dividend increases. While the company recently spun off its consumer health division (Kenvue), the rem...